30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
Canada Pharmaceuticals

RIV Capital Inc (RIV)

Track

Stock chart
Ticker: RIV Exchange: CNX
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Vautrin, David Ernest
Senior Officer of Issuer
5 purchases — total 11,576 USD
Buy 10 Dec 2024
Value US$3,340,876.35 | Price 172.25 | Shares 4,711
Buy 10 Dec 2024
Value US$3,446,788.33 | Price 186.46 | Shares 12,235
Buy 10 Dec 2024
Value US$104.80 | Price 0.10 | Shares 1,000
Buy 10 Dec 2024
Value US$303.00 | Price 0.10 | Shares 3,000
Buy 10 Dec 2024
Value US$2,497.50 | Price 0.10 | Shares 25,000
Buy 9 Dec 2024
Value US$830,979.29 | Price 268.19 | Shares 74,094
Buy 9 Dec 2024
Value US$1,890,244.27 | Price 10.23 | Shares 73,691
Buy 9 Dec 2024
Value US$300.00 | Price 0.10 | Shares 3,000
Buy 9 Dec 2024
Value US$598.20 | Price 0.10 | Shares 6,000
Buy 10 Oct 2024
Value US$14,245.00 | Price 0.15 | Shares 96,250
Buy 9 Oct 2024
Value US$695.25 | Price 0.14 | Shares 5,150
Buy 4 Oct 2024
Value US$3,024.00 | Price 0.14 | Shares 21,600
Buy 3 Oct 2024
Value US$280.00 | Price 0.14 | Shares 2,000
Buy 19 Sep 2024
Value US$1,088.87 | Price 0.17 | Shares 6,443
Buy 19 Sep 2024
Value US$5,606.25 | Price 0.16 | Shares 34,500
Buy 19 Sep 2024
Value US$3,240.00 | Price 0.16 | Shares 20,000
Buy 19 Sep 2024
Value US$3,218.00 | Price 0.16 | Shares 20,000
Buy 19 Sep 2024
Value US$16,496.00 | Price 0.16 | Shares 103,100
Buy 19 Sep 2024
Value US$6,359.50 | Price 0.16 | Shares 39,500
Buy 19 Sep 2024
Value US$4,797.00 | Price 0.16 | Shares 30,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-16 2024-12-10 B Purchase
Vautrin, David Ernest

Senior Officer of Issuer

Officer
4,711 +46.3%
172.25
US$3,340,876 		4,711 +46.3% 172.25 US$3,340,876
2024-12-16 2024-12-10 B Purchase
Vautrin, David Ernest

Senior Officer of Issuer

Officer
12,235 -8.2%
186.46
US$3,446,788 		12,235 -8.2% 186.46 US$3,446,788
2024-12-16 2024-12-10 B Purchase
Vautrin, David Ernest

Senior Officer of Issuer

Officer
31,939 -6.8%
197.99
US$1,120,773 		31,939 -6.8% 197.99 US$1,120,773
2024-12-16 2024-12-10 B Purchase
Vautrin, David Ernest

Senior Officer of Issuer

Officer
3,000 +0.2%
0.10
US$303 		3,000 +0.2% 0.10 US$303
2024-12-16 2024-12-10 B Purchase
Vautrin, David Ernest

Senior Officer of Issuer

Officer
25,000 +2.0%
0.10
US$2,498 		25,000 +2.0% 0.10 US$2,498
2024-12-16 2024-12-09 B Purchase
Vautrin, David Ernest

Senior Officer of Issuer

Officer
12,500 +1.0%
0.11
US$1,322 		12,500 +1.0% 0.11 US$1,322
2024-12-16 2024-12-09 B Purchase
Vautrin, David Ernest

Senior Officer of Issuer

Officer
16,000 +1.3%
0.10
US$1,664 		16,000 +1.3% 0.10 US$1,664
2024-12-16 2024-12-09 B Purchase
Vautrin, David Ernest

Senior Officer of Issuer

Officer
3,000 +0.2%
0.10
US$300 		3,000 +0.2% 0.10 US$300
2024-12-16 2024-12-09 B Purchase
Vautrin, David Ernest

Senior Officer of Issuer

Officer
6,000 +0.5%
0.10
US$598 		6,000 +0.5% 0.10 US$598
2024-10-11 2024-10-10 B Purchase
Vautrin, David Ernest

Senior Officer of Issuer

Officer
96,250 +8.6%
0.15
US$14,245 		96,250 +8.6% 0.15 US$14,245
2024-10-11 2024-10-09 B Purchase
Vautrin, David Ernest

Senior Officer of Issuer

Officer
5,150 +0.5%
0.14
US$695 		5,150 +0.5% 0.14 US$695
2024-10-11 2024-10-04 B Purchase
Vautrin, David Ernest

Senior Officer of Issuer

Officer
21,600 +2.0%
0.14
US$3,024 		21,600 +2.0% 0.14 US$3,024
2024-10-11 2024-10-03 B Purchase
Vautrin, David Ernest

Senior Officer of Issuer

Officer
2,000 +0.2%
0.14
US$280 		2,000 +0.2% 0.14 US$280
2024-09-20 2024-09-19 B Purchase
Vautrin, David Ernest

Senior Officer of Issuer

Officer
6,443 +0.6%
0.17
US$1,089 		6,443 +0.6% 0.17 US$1,089
2024-09-20 2024-09-19 B Purchase
Vautrin, David Ernest

Senior Officer of Issuer

Officer
34,500 +3.4%
0.16
US$5,606 		34,500 +3.4% 0.16 US$5,606
2024-09-20 2024-09-19 B Purchase
Vautrin, David Ernest

Senior Officer of Issuer

Officer
20,000 +2.0%
0.16
US$3,240 		20,000 +2.0% 0.16 US$3,240
2024-09-20 2024-09-19 B Purchase
Vautrin, David Ernest

Senior Officer of Issuer

Officer
20,000 +2.0%
0.16
US$3,218 		20,000 +2.0% 0.16 US$3,218
2024-09-20 2024-09-19 B Purchase
Vautrin, David Ernest

Senior Officer of Issuer

Officer
103,100 +11.8%
0.16
US$16,496 		103,100 +11.8% 0.16 US$16,496
2024-09-20 2024-09-19 B Purchase
Vautrin, David Ernest

Senior Officer of Issuer

Officer
39,500 +4.7%
0.16
US$6,360 		39,500 +4.7% 0.16 US$6,360
2024-09-20 2024-09-19 B Purchase
Vautrin, David Ernest

Senior Officer of Issuer

Officer
30,000 +3.7%
0.16
US$4,797 		30,000 +3.7% 0.16 US$4,797
Explore more

More insider trading research around RIV Capital Inc

More insider trades in Canada
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America